Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31453054 | 0.89 | KMT2A (0.48) | NPC1RAB9AALDH1A1KDM4EMEN1 | |
| SCHEMBL26602407 | 0.88 | NPC1 (0.54) | NPC1RAB9AALDH1A1KDM4EMEN1 | |
| SCHEMBL31453060 | 0.88 | NPC1 (0.54) | NPC1RAB9AALDH1A1KDM4EMEN1 | |
| SCHEMBL31453037 | 0.87 | MCL1 (0.55) | NPC1RAB9AALDH1A1KDM4EMEN1 | |
| SCHEMBL31453040 | 0.87 | GAA (0.48) | NPC1RAB9AALDH1A1KDM4EMEN1 | |
| SCHEMBL31453063 | 0.84 | GAA (0.44) | NPC1RAB9AALDH1A1KDM4EMEN1 | |
| SCHEMBL31453039 | 0.84 | KDM4E (0.60) | NPC1RAB9AALDH1A1KDM4EMEN1 | |
| SCHEMBL31453062 | 0.83 | KDM4E (0.48) | NPC1RAB9AALDH1A1KDM4EMEN1 | |
| SCHEMBL31453066 | 0.81 | ALDH1A1 (0.48) | NPC1RAB9AALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL31453046 | 0.81 | MCL1 (0.49) | NPC1RAB9AALDH1A1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250275958-A1 | GPCR REGULATOR AND USE THEREOF | Beijing Changping Laboratory (CN) | 2025-09-04 | — | — | US | disclosed |
| EP-4512803-A1 | GPCR REGULATOR AND USE THEREOF | Beijing Changping Laboratory (CN) | 2025-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275958-A1 | GPCR REGULATOR AND USE THEREOF | ARRB1, GPR3, GPR4 | NPC1 785/4885RAB9A 696/4885MTNR1A 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.